Search - tctmd.com

Displaying 341 - 360 of 626

Sort: Relevancy | Date

Presentation LAA 2014

Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL)

Presenter: David R. Holmes

July 19, 2014

Presentation LAA 2014

Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more

Presenter: Vivek Y. Reddy

July 19, 2014

Presentation LAA 2014

Outcomes Data with the Amplatzer Cardiac Plug in Anticoagulant Eligible and Ineligible Patients

Presenter: Josep Rod?s-Cabau

July 19, 2014

Presentation LAA 2014

Novel Anticoagulants

Presenter: Michael D. Ezekowitz

July 17, 2014

News Daily News

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

Yael L. Maxwell

July 17, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

Long-term Cardiac Rhythm Monitoring More Likely to Detect A-fib After Cryptogenic Stroke

L.A. McKeown

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Daily News

La Monitorización a Largo Plazo del Ritmo Cardíaco es Capaz de Detectar FA Post-ACV Criptogénico

L.A. McKeown

July 03, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Daily News

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Yael L. Maxwell

June 24, 2014

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

News Daily News

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Jason Kahn

May 15, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Industry News

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

May 07, 2014

Presentation

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Presenter: K. Goto

April 30, 2014

Advertisement

Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL)

Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more

Outcomes Data with the Amplatzer Cardiac Plug in Anticoagulant Eligible and Ineligible Patients

Novel Anticoagulants

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

Long-term Cardiac Rhythm Monitoring More Likely to Detect A-fib After Cryptogenic Stroke

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

La Monitorización a Largo Plazo del Ritmo Cardíaco es Capaz de Detectar FA Post-ACV Criptogénico

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content